WinRho® SDF


WinRho® SDF [Rho (D) Immune Globulin (Human) for Injection]

WinRho® SDF, [Rho (D) Immune Globulin (Human) for Injection], Cangene’s flagship product, is sold worldwide and is available either as a liquid formulation or a freeze-dried powder. 

WinRho® SDF is known as an anti-D product and is approved for two distinct indications.

WinRho® SDF was developed in 1968 by renowned pediatric researchers, Drs. Bruce Chown and John (Jack) Bowman. These physicians gained global recognition as pioneers for treating hemolytic disease of the newborn. In appreciation of their achievements, both physicians were made Officers of the Order of Canada.

*Product Information based on Canadian Product Monograph

The following information is available in .pdf

Canadian Product Monographs:


For Canadian Healthcare Professionals
WinRho®SDF Safety Update
English / French

For Residents of Canada
WinRho®SDF Public Notification
English / French

WinRho® SDF Product Inquiries

Tel: 1-877-226-4363

Tel: 01 (204) 275-4178

Medical Affairs:

Tel: 1-800-768-2304

Manufactured and distributed by Cangene Corporation. WinRho SDF® and any and all Emergent BioSolutions Inc. brand, product, service and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All rights reserved.